Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinalbuphine Sebacate for Postoperative Pain in UPPP Patients
NCT05825495Phase 4Unknown
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dinalbuphine sebacate in postoperative pain. Status: unknown.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05825495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825495.